These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

460 related items for PubMed ID: 29529610

  • 1. Glucocorticoids Reduce Aberrant O-Glycosylation of IgA1 in IgA Nephropathy Patients.
    Kosztyu P, Hill M, Jemelkova J, Czernekova L, Kafkova LR, Hruby M, Matousovic K, Vondrak K, Zadrazil J, Sterzl I, Mestecky J, Raska M.
    Kidney Blood Press Res; 2018; 43(2):350-359. PubMed ID: 29529610
    [Abstract] [Full Text] [Related]

  • 2. IgA nephropathy and Henoch-Schoenlein purpura nephritis: aberrant glycosylation of IgA1, formation of IgA1-containing immune complexes, and activation of mesangial cells.
    Novak J, Moldoveanu Z, Renfrow MB, Yanagihara T, Suzuki H, Raska M, Hall S, Brown R, Huang WQ, Goepfert A, Kilian M, Poulsen K, Tomana M, Wyatt RJ, Julian BA, Mestecky J.
    Contrib Nephrol; 2007; 157():134-8. PubMed ID: 17495451
    [Abstract] [Full Text] [Related]

  • 3. IgA glycosylation and IgA immune complexes in the pathogenesis of IgA nephropathy.
    Novak J, Julian BA, Tomana M, Mestecky J.
    Semin Nephrol; 2008 Jan; 28(1):78-87. PubMed ID: 18222349
    [Abstract] [Full Text] [Related]

  • 4. The pathogenic role of IgA1 O-linked glycosylation in the pathogenesis of IgA nephropathy.
    Barratt J, Smith AC, Feehally J.
    Nephrology (Carlton); 2007 Jun; 12(3):275-84. PubMed ID: 17498123
    [Abstract] [Full Text] [Related]

  • 5. Serum under-O-glycosylated IgA1 level is not correlated with glomerular IgA deposition based upon heterogeneity in the composition of immune complexes in IgA nephropathy.
    Satake K, Shimizu Y, Sasaki Y, Yanagawa H, Suzuki H, Suzuki Y, Horikoshi S, Honda S, Shibuya K, Shibuya A, Tomino Y.
    BMC Nephrol; 2014 Jun 13; 15():89. PubMed ID: 24928472
    [Abstract] [Full Text] [Related]

  • 6. Aberrant glycosylation of IgA1 and anti-glycan antibodies in IgA nephropathy: role of mucosal immune system.
    Novak J, Moldoveanu Z, Julian BA, Raska M, Wyatt RJ, Suzuki Y, Tomino Y, Gharavi AG, Mestecky J, Suzuki H.
    Adv Otorhinolaryngol; 2011 Jun 13; 72():60-3. PubMed ID: 21865691
    [Abstract] [Full Text] [Related]

  • 7. O-glycosylation of IgA1 and the pathogenesis of an autoimmune disease IgA nephropathy.
    Novak J, King RG, Yother J, Renfrow MB, Green TJ.
    Glycobiology; 2024 Sep 30; 34(11):. PubMed ID: 39095059
    [Abstract] [Full Text] [Related]

  • 8. Aberrantly glycosylated IgA1 in IgA nephropathy patients is recognized by IgG antibodies with restricted heterogeneity.
    Suzuki H, Fan R, Zhang Z, Brown R, Hall S, Julian BA, Chatham WW, Suzuki Y, Wyatt RJ, Moldoveanu Z, Lee JY, Robinson J, Tomana M, Tomino Y, Mestecky J, Novak J.
    J Clin Invest; 2009 Jun 30; 119(6):1668-77. PubMed ID: 19478457
    [Abstract] [Full Text] [Related]

  • 9. Aberrant Glycosylation of the IgA1 Molecule in IgA Nephropathy.
    Novak J, Barratt J, Julian BA, Renfrow MB.
    Semin Nephrol; 2018 Sep 30; 38(5):461-476. PubMed ID: 30177018
    [Abstract] [Full Text] [Related]

  • 10. Recognition of galactose-deficient O-glycans in the hinge region of IgA1 by N-acetylgalactosamine-specific snail lectins: a comparative binding study.
    Gomes MM, Suzuki H, Brooks MT, Tomana M, Moldoveanu Z, Mestecky J, Julian BA, Novak J, Herr AB.
    Biochemistry; 2010 Jul 13; 49(27):5671-82. PubMed ID: 20507092
    [Abstract] [Full Text] [Related]

  • 11. O- and N-Glycosylation of Serum Immunoglobulin A is Associated with IgA Nephropathy and Glomerular Function.
    Dotz V, Visconti A, Lomax-Browne HJ, Clerc F, Hipgrave Ederveen AL, Medjeral-Thomas NR, Cook HT, Pickering MC, Wuhrer M, Falchi M.
    J Am Soc Nephrol; 2021 Oct 13; 32(10):2455-2465. PubMed ID: 34127537
    [Abstract] [Full Text] [Related]

  • 12. IgA nephropathy: an update.
    Julian BA, Novak J.
    Curr Opin Nephrol Hypertens; 2004 Mar 13; 13(2):171-9. PubMed ID: 15202611
    [Abstract] [Full Text] [Related]

  • 13. Circulating immune complexes in IgA nephropathy consist of IgA1 with galactose-deficient hinge region and antiglycan antibodies.
    Tomana M, Novak J, Julian BA, Matousovic K, Konecny K, Mestecky J.
    J Clin Invest; 1999 Jul 13; 104(1):73-81. PubMed ID: 10393701
    [Abstract] [Full Text] [Related]

  • 14. Both IgA nephropathy and alcoholic cirrhosis feature abnormally glycosylated IgA1 and soluble CD89-IgA and IgG-IgA complexes: common mechanisms for distinct diseases.
    Tissandié E, Morelle W, Berthelot L, Vrtovsnik F, Daugas E, Walker F, Lebrec D, Trawalé JM, Francoz C, Durand F, Moura IC, Paradis V, Moreau R, Monteiro RC.
    Kidney Int; 2011 Dec 13; 80(12):1352-63. PubMed ID: 21866091
    [Abstract] [Full Text] [Related]

  • 15. Glycosylation of IgA1 and pathogenesis of IgA nephropathy.
    Novak J, Julian BA, Mestecky J, Renfrow MB.
    Semin Immunopathol; 2012 May 13; 34(3):365-82. PubMed ID: 22434325
    [Abstract] [Full Text] [Related]

  • 16. Sparsentan ameliorates glomerular hypercellularity and inflammatory-gene networks induced by IgA1-IgG immune complexes in a mouse model of IgA nephropathy.
    Reily C, Moldoveanu Z, Pramparo T, Hall S, Huang ZQ, Rice T, Novak L, Komers R, Jenkinson CP, Novak J.
    Am J Physiol Renal Physiol; 2024 May 01; 326(5):F862-F875. PubMed ID: 38511222
    [Abstract] [Full Text] [Related]

  • 17. [IgA1 aberrant glycosylation in the pathogenesis of IgA nephropathy: an overivew].
    Xie L, Wang L, Huang J, Fan J.
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2010 Feb 01; 27(1):227-30. PubMed ID: 20337060
    [Abstract] [Full Text] [Related]

  • 18. Role of aberrant glycosylation of IgA1 molecules in the pathogenesis of IgA nephropathy.
    Mestecky J, Tomana M, Moldoveanu Z, Julian BA, Suzuki H, Matousovic K, Renfrow MB, Novak L, Wyatt RJ, Novak J.
    Kidney Blood Press Res; 2008 Feb 01; 31(1):29-37. PubMed ID: 18182777
    [Abstract] [Full Text] [Related]

  • 19. Paradigm shift in activity assessment of IgA nephropathy - optimizing the next generation of diagnostic and therapeutic maneuvers via glycan targeting.
    Suzuki Y, Suzuki H, Yasutake J, Tomino Y.
    Expert Opin Biol Ther; 2015 Apr 01; 15(4):583-93. PubMed ID: 25604055
    [Abstract] [Full Text] [Related]

  • 20. IgA glycosylation and immune complex formation in IgAN.
    Suzuki H, Novak J.
    Semin Immunopathol; 2021 Oct 01; 43(5):669-678. PubMed ID: 34570260
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.